Recombinant Human Protein RER1 (RER1)

What is RER1 and what are its primary cellular functions?

RER1 is a multi-pass membrane protein that functions as an essential component for retention and retrieval of proteins in the early secretory pathway. The primary functions of RER1 include:

• Retrieval of endoplasmic reticulum (ER) membrane proteins from the early Golgi compartment

• Regulation of ER retention of immature or misfolded proteins

• Modulation of protein complex assembly, particularly for multi-subunit membrane protein complexes

• Quality control for membrane proteins in the early secretory pathway

Human RER1 consists of 196 amino acids, corresponding to a molecular mass of approximately 23 kDa, and shares 44% identity and 65% similarity with yeast Rer1 protein . The protein contains four putative transmembrane domains that form a W-topology with both N- and C-termini facing the cytosol .

Where is RER1 localized in human cells?

Human RER1 is primarily localized to the Golgi apparatus and peripheral elements of the ER-Golgi interface . This localization has been confirmed through multiple experimental approaches:

• Double immunofluorescence microscopy

• Immunoelectron microscopy of thawed cryosections

• Subcellular distribution analysis with organelle markers

Interestingly, under conditions of brefeldin A treatment, human RER1 redistributes together with recycling Golgi proteins, demonstrating its dynamic behavior within the secretory pathway . High overexpression of RER1 can lead to its relocation to ER-like structures together with KDEL-receptor and can affect the structural organization of the Golgi apparatus .

What expression systems are used to produce recombinant human RER1?

Multiple expression systems have been employed to produce recombinant human RER1 protein:

The choice of expression system depends on the experimental requirements. For structural studies or functional assays, mammalian expression systems are preferred to ensure proper folding and modifications . For applications requiring specific protein fragments, such as antibody validation, bacterial expression systems can be more efficient .

How can recombinant RER1 be used in protein interaction studies?

Recombinant RER1 can be utilized in various protein interaction studies to investigate its role in protein trafficking:

• Co-immunoprecipitation assays: Using tagged recombinant RER1 to pull down interacting partners from cell lysates. This approach has successfully identified interactions with:

  • Wild-type and mutant rhodopsin

  • Components of the γ-secretase complex

  • Mutant peripheral myelin protein 22 (PMP22)

• In vitro binding assays: Purified recombinant RER1 can be used in GST pull-down or surface plasmon resonance (SPR) experiments to assess direct interactions and binding kinetics.

• Competition assays: Recombinant RER1 fragments can be used to compete with endogenous RER1 for binding to target proteins, helping map interaction domains.

When designing interaction experiments, researchers should consider using mild detergents to maintain membrane protein interactions and include appropriate controls to distinguish specific from non-specific interactions .

How does RER1 contribute to protein quality control in the secretory pathway?

RER1 functions as a critical component of protein quality control through two primary mechanisms:

• Retrieval function: RER1 recognizes specific motifs in proteins that have escaped the ER and facilitates their retrieval from the early Golgi back to the ER . This process is particularly important for:

  • Misfolded proteins that need ER retention for potential refolding

  • Subunits of multi-protein complexes awaiting assembly partners

  • ER-resident proteins that have escaped their normal location

• Retention function: RER1 can directly contribute to the retention of certain proteins in the ER, preventing their forward transport through the secretory pathway .

Experimental evidence demonstrates these functions in multiple systems:

• In studies with rhodopsin, RER1 regulates wild-type rhodopsin trafficking and specifically mediates the ER retention of the G51R rhodopsin mutant

• Knockdown of RER1 increases the transport of wild-type rhodopsin and allows G51R mutant rhodopsin to escape to the plasma membrane or lysosomes

• In Charcot-Marie-Tooth disease models, RER1 works alongside calnexin to trap disease-related PMP22(L16P) in the ER

These findings highlight RER1's role as a "sorting chaperone" that modulates the fate of various membrane proteins in the early secretory pathway.

What experimental approaches are effective for studying RER1-mediated protein trafficking?

To investigate RER1-mediated protein trafficking, researchers can employ several complementary approaches:

• Loss-of-function and gain-of-function studies:

  • siRNA or shRNA knockdown of RER1 to assess effects on protein localization and trafficking

  • Overexpression of wild-type or tagged RER1 to examine retention effects

  • Rescue experiments with siRNA-resistant RER1 constructs to confirm specificity

• Protein localization and trafficking assays:

  • Immunofluorescence microscopy to visualize subcellular distribution of cargo proteins

  • Cell surface biotinylation to quantify plasma membrane localization of proteins

  • Live-cell imaging with fluorescently tagged proteins to monitor dynamic trafficking

• Biochemical approaches:

  • Subcellular fractionation to isolate and analyze different compartments

  • Glycosidase sensitivity assays (EndoH vs. PNGaseF) to determine protein trafficking through the Golgi

  • Cycloheximide chase experiments to distinguish trafficking from new protein synthesis

A successful experimental design might combine RER1 knockdown with cell surface biotinylation and confocal microscopy to provide both biochemical and visual evidence of altered protein trafficking, as demonstrated in studies of rhodopsin trafficking .

How does RER1 contribute to the pathophysiology of protein misfolding diseases?

RER1 plays a significant role in several protein misfolding diseases through its function in quality control:

• Charcot-Marie-Tooth disease: RER1 participates in trapping disease-related PMP22(L16P) mutant in the ER through calnexin-dependent ER retention and RER1-mediated early Golgi retrieval . Simultaneous knockdown of RER1 and calnexin leads to more pronounced release of PMP22(L16P) from the ER than knockdown of each gene individually .

• Retinitis pigmentosa: RER1 regulates the ER retention of certain rhodopsin mutants, such as G51R . Depletion of RER1 results in the release of this mutant from the ER to the plasma membrane or lysosomes .

• Neurodegenerative disorders: RER1 modulates γ-secretase complex assembly and function by interacting with unassembled nicastrin and PEN-2, which has implications for Alzheimer's disease pathology .

These findings suggest that RER1's role in disease pathophysiology may be mutation-specific and depends on the nature of the protein misfolding.

How can experimental design address the contradictory effects of RER1 on different mutant proteins?

Studies have shown that RER1 exhibits differential effects on various mutant proteins, presenting an experimental challenge. For example, RER1 knockdown allows G51R rhodopsin mutant to reach the plasma membrane but has minimal effect on P23H and L40R rhodopsin mutants . To address these contradictions, researchers should:

• Design comparative studies with multiple mutants:

  • Analyze multiple mutations within the same protein (as done with different rhodopsin mutants)

  • Include wild-type proteins as controls

  • Quantify trafficking effects using consistent metrics across experiments

• Investigate domain-specific interactions:

  • Use domain mapping to identify which regions of RER1 interact with different mutants

  • Create chimeric proteins to determine which features confer RER1 sensitivity

  • Implement site-directed mutagenesis to alter potential interaction sites

• Employ multiple methodological approaches:

  • Combine visual techniques (immunofluorescence) with quantitative biochemical assays (surface biotinylation)

  • Use complementary overexpression and knockdown experiments

  • Implement rescue experiments with specific domains to identify functional regions

When analyzing data from such experiments, researchers should consider:

• Quantitative analysis of subcellular distribution

• Statistical comparison across multiple mutants

• Correlation between protein structure/mutation location and RER1 effects

What are the critical controls when using recombinant RER1 in experimental studies?

When working with recombinant RER1 protein, several critical controls should be implemented:

• Protein quality controls:

  • Verify purity by SDS-PAGE and Coomassie blue staining (aim for >80% purity)

  • Confirm protein identity using mass spectrometry or Western blotting

  • Assess proper folding through functional assays (e.g., binding to known partners)

• Application-specific controls:

  • For blocking experiments with antibodies: Use a 100x molar excess of the protein fragment based on concentration and molecular weight

  • Include irrelevant recombinant proteins of similar size as negative controls

  • For functional complementation: Test with known RER1-dependent and independent cargoes

• Experimental system validation:

  • When using tagged RER1 constructs, verify that tags do not interfere with function or localization

  • For knockdown/knockout studies, include rescue experiments with recombinant RER1

  • When studying trafficking, include Brefeldin A treatment as a positive control for Golgi disruption

How should researchers design experiments to study the functional activity of recombinant human RER1?

Designing experiments to assess the functional activity of recombinant human RER1 requires careful consideration:

• Complementation assays:

  • Use RER1-deficient cells (through CRISPR knockout or siRNA knockdown)

  • Introduce recombinant RER1 and assess rescue of phenotypes

  • Measure recovery of proper localization of known RER1-dependent cargoes

• Trafficking assays:

  • Monitor localization of model cargoes (e.g., rhodopsin, PMP22) in the presence/absence of recombinant RER1

  • Quantify surface expression using biotinylation assays or flow cytometry

  • Track protein movement using live-cell imaging with fluorescently tagged proteins

• Structure-function analysis:

  • Generate domain deletions or point mutations in recombinant RER1

  • Assess which domains are required for different functions (Golgi localization, cargo binding)

  • Create chimeric proteins with domains from other species to identify conserved functional regions

The functional activity of recombinant human RER1 can be validated through complementation of RER1 deletion in model systems, as demonstrated with myc-tagged human RER1 complementing yeast Rer1p function .